HHLA1: A Drug Target / Disease Biomarker (G10086)

Target Name: HHLA1

NCBI ID: G10086

HHLA1

Other Name(s): PLA2L | HHLA1_HUMAN | HERV-H LTR-associating protein 1 | HERV-H LTR-associating 1

HHLA1: A Drug Target / Disease Biomarker

HHLA1 is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and eyes. It is a member of the human leukocyte antigen (HLA) family, which consists of a large group of proteins that are involved in the immune system.

One of the functions of HHLA1 is to help regulate the immune response. It is involved in the development and maintenance of the immune system, and it has been shown to play a role in the regulation of inflammation.

HHLA1 is also a potential drug target. Researchers have identified several potential small molecules that can interact with HHLA1 and enhance its activity. These molecules have the potential to be used to treat a variety of diseases, including cancer, autoimmune disorders, and inflammatory diseases.

One of the small molecules that has been shown to interact with HHLA1 is called HLX-21. HLX-21 is a compound that was developed by the company Genoptix and is being investigated for its potential as a treatment for skin cancer.

In addition to its potential as a drug, HHLA1 is also a potential biomarker. Its expression has been shown to be elevated in a variety of diseases, including cancer, and it has been used as a biomarker in several studies.

One of the challenges in studying HHLA1 is its complex structure. HHLA1 is a transmembrane protein, which means that it spans the cell membrane and is involved in the regulation of what happens inside the cell. This makes it difficult to study and understand its function fully.

However, researchers have made some progress in understanding the structure and function of HHLA1. One of the key findings of recent studies is that HHLA1 has a complex structure that is involved in its function.

Research has shown that HHLA1 has a large extracellular domain, which is involved in its interactions with other proteins. This domain is composed of a variety of amino acids that are involved in the formation of hydrogen bonds and other types of interactions.

In addition to its extracellular domain, HHLA1 also has a transmembrane region, which is responsible for the fact that it spans the cell membrane. This region is composed of a variety of amino acids that are involved in the formation of ion channels and other types of transmembrane structures.

Overall, the structure and function of HHLA1 are complex and still not fully understood. Further research is needed to fully understand its role in the immune system and its potential as a drug and biomarker.

Protein Name: HERV-H LTR-associating 1

The "HHLA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HHLA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets